Showing results (301-310 of 373) with videos related to
Sort By:
Pageof 38
Oncotarget|December 2, 2017
Genes co-amplified with ERBB2 or MET as novel potential cancer-promoting genes in gastric cancerMi Jeong Kwon, Ryong Nam Kim, Kyoung Song, et al.BMC Cancer|October 6, 2010
Favorable response to doxorubicin combination chemotherapy does not yield good clinical outcome in patients with metastatic breast cancer with triple-negative phenotypeSeong Yoon Yi, Jin Seok Ahn, Ji Eun Uhm, et al.Lung Cancer (Amsterdam, Netherlands)|December 31, 2025
The role of APOBEC in early-stage epidermal growth factor receptor-mutant non-small cell lung cancerHyun Ae Jung, Jinyeong Lim, Yoon-La Choi, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 11, 2016
Acquired C797S Mutation upon Treatment with a T790M-Specific Third-Generation EGFR Inhibitor (HM61713) in Non-Small Cell Lung CancerHaa-Na Song, Ki Sun Jung, Kwai Han Yoo, et al.Breast Cancer Research and Treatment|April 15, 2017
MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancerJinil Han, Yoon-La Choi, Haein Kim, et al.Scientific Reports|May 18, 2018
Genomic alterations of ground-glass nodular lung adenocarcinomaHyun Lee, Je-Gun Joung, Hyun-Tae Shin, et al.BMC Cancer|September 24, 2010
Triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survivalYoon-La Choi, Ensel Oh, Sarah Park, et al.Molecular Cancer Therapeutics|August 25, 2011
Impact of KRAS mutations on clinical outcomes in pancreatic cancer patients treated with first-line gemcitabine-based chemotherapySeung Tae Kim, Do Hyoung Lim, Kee-Taek Jang, et al.Human Pathology|June 27, 2003
Detection of germinal center B-cell lymphoma in archival specimens: critical evaluation of Bcl-6 protein expression in diffuse large B-cell lymphoma of the tonsilHowe J Ree, Koichi Ohsima, Katsuyuki Aozasa, et al.Breast Cancer Research and Treatment|December 4, 2009
A risk stratification by hormonal receptors (ER, PgR) and HER-2 status in small (< or = 1 cm) invasive breast cancer: who might be possible candidates for adjuvant treatment?Yeon Hee Park, Seung Tae Kim, Eun Yoon Cho, et al.Pageof 38